Impact of oxidative stress on human cytomegalovirus replication and on cytokine-mediated stimulation of endothelial cells

Transplantation

Volumn 61, Issue 12, 1996, Pages 1763-1770

  Scholz, Martin ^a   Cinatl, Jindrich ^a   Gross, Volker ^a   Vogel, Jens U ^a   Blaheta, Roman A ^a   Freisleben, H Joachim ^a   Markus, Bernd H ^a   Doerr, Hans W ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BUTHIONINE SULFOXIMINE; CYTOKINE; DNA; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GAMMA INTERFERON; HLA ANTIGEN; HLA DR ANTIGEN; IMMEDIATE EARLY PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1; PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VIRUS ANTIGEN;

ARTICLE; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; FLUOROMETRY; GRAFT REJECTION; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; INFLAMMATION; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSPLANTATION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS SHEDDING;

BASE SEQUENCE; BUTHIONINE SULFOXIMINE; CELL ADHESION MOLECULES; CELLS, CULTURED; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; ENDOTHELIUM, VASCULAR; HLA ANTIGENS; HLA-DR ANTIGENS; HUMANS; METHIONINE SULFOXIMINE; MOLECULAR SEQUENCE DATA; OXIDATION-REDUCTION; OXIDATIVE STRESS; STIMULATION, CHEMICAL; SULFHYDRYL COMPOUNDS; VIRUS REPLICATION;

EID: 0029957708     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199606270-00017     Document Type: Article

References (42)

1. Huang E-S, Kowalik TF. The pathogenicity of human cytomegalovirus: an overview. In: Becker Y, Darai G, eds. Frontiers of virology 2. Molecular aspects of human cytomegalovirus diseases. New York: Springer-Verlag, 1993: 3.
2. Ho M. Clinical manifestations of cytomegalovirus infections in the immunosuppressed. In: Ho M, ed. Cytomegalovirus: biology and infection. 2nd ed. New York: Plenum, 1991: 275.
3. Von Willebrand E, Petterson E, Ahonen J, Häyry P. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 1986; 42: 364.
4. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
5. Scholz M, Hamann A, Blaheta RA, Auth MKH, Encke A, Markus BH. Cytomegalovirus- and interferon-related effects on human endothelial cells: cytomegalovirus infection reduces up-regulation of HLA class II antigen expression after treatment with interferon-gamma. Human Immunol 1992; 35: 230.
6. Scholz M, Blaheta RA, Cinatl J, Encke A, Doerr HW, Markus BH. Lymphocytes induce enhanced expression of HLA class I antigens on cytomegalovirus-infected syngeneic human endothelial cells. Human Immunol 1995; 44: 136.
7. Tribble DL, Aw TY, Jones DP. The pathophysiological significance of lipid peroxidation in oxidative cell injury. Hepatology 1987; 7: 377.
8. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. New Engl J Med 1985; 312: 159.
9. Southard JH, Marsh DC, McAnulty JF, Belzer FO. Oxygen-derived free radical damage in organ preservation: activity of superoxide dismutase and xanthine oxidase. Surgery 1987; 101: 566.
10. Parks DA, Granger DN. Ischemia-reperfusion injury. A radical view. Hepatology 1988; 8: 680.
11. Metzger J, Dore SP, Lauterburg BH. Oxidant stress during reperfusion of ischemic liver: no evidence for a role of xanthine oxidase. Hepatology 1988; 8: 580.
12. Clavien P-A, Harvey RC, Strasberg SM. Preservation and reperfusion injuries in liver allografts. An overview and synthesis of current studies. Transplantation 1992; 53: 957.
13. Droge W, Eck H-P, Mihm S. HIV-induced cysteine deficiency and T-cell dysfunction - a rationale for treatment with N-acetylcysteine. Immunol Today 1992; 13: 211.
14. Roederer M, Ela SW, Staal FJT, Herzenberg LA, Herzenberg LA. N-acetylcysteine: a new approach to anti-HIV therapy. Aids Res Hum Retroviruses 1992; 8: 209.
15. Kalebic T, Kinter A, Poli G, Anderson ME, Meister A, Fauci AS. Suppression of HIV expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine. Proc Natl Acad Sci (USA) 1991; 88: 986.
16. Mihm S, Ennen J, Pessara U, Kurth R, Dröge W. Inhibition of HIV-1 replication and NF-kappa B activity by cysteine and cysteine derivates. AIDS 1991; 5: 497.
17. Roederer M, Raju PA, Staal FJT, Herzenberg LA, Herzenberg LA. N-acetylcysteine inhibits latent HIV expression in chronically infected cells. AIDS Res Hum Retroviruses 1991; 7: 563.
18. Staal FJT, Roederer M, Herzenberg LA, Herzenberg LA. Intracellular thiols regulate activation of nuclear factor kappa B and transcription of human immunodeficiency virus. Proc Natl Acad Sci (USA) 1990; 87: 9943.
19. Folks TM, Clouse PCA, Justement J, et al. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T cell clone. Proc Natl Acad Sci (USA) 1989; 86: 2365.
20. Poli G, Bressler P, Kinter A, et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms. J Exp Med 1990; 172: 151.
21. Stanley SK, Bressler PB, Poli G, Fauci AS. Heat shock induction of HIV production from chronically infected promonocytic and T cell lines. J Immunol 1990; 145: 1120.
22. Döcke WD, Prösch S, Fietze E, et al. Cytomegalovirus reactivation and tumor necrosis factor. Lancet 1994; 343: 268.
23. Fietze E, Prösch S, Reinke P, et al. Cytomegalovirus infection in transplant recipients: role of tumor necrosis factor. Transplantation 1994; 58: 675.
24. Cross AR, Jones OTG. Enzymic mechanisms of superoxide production. Biochim Biophys Acta 1991; 1057: 281.
25. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphology and immunological criteria. J Clin Invest 1973; 52: 2745.
26. Radsak K, Fuhrmann R, Franke RP, et al. Induction by sodium butyrate of cytomegalovirus replication in human endothelial cells. Arch Virol 1989; 107: 151.
27. Meister A. Selective modification of glutathione metabolism. Science 1983; 220: 472.
28. Meister A. Methods for the selective modification of glutathione metabolism and study of glutathione transport. Methods Enzymol 1985; 113: 571.
29. Kosower N, Kosower EM, Newton GL, Ranney HM. Bimane fluorescent labels: labeling of normal human red cells under physiological conditions. Proc Natl Acad Sci (USA) 1979; 76: 3382.
30. Freisleben H-J, Fuchs J, Mainka L, Zimmer G. Reactivity of mitochondrial sulfhydryl groups toward dithionitrobenzoic acid and bromobimanes under oligomycin-inhibited and uncoupling conditions. Arch Biochem Biophys 1988; 266: 89.
31. Scholz M, Blaheta RA, Görlich C, et al. Investigations on cellular infection with human cytomegalovirus in vitro: activation and suppression of the cellular immune response. TX Med 1993; 6: 72.
32. Braun W, Schacherer C. Rapid (24h) neutralization assay for the detection of antibodies to human cytomegalovirus using a monoclonal antibody to an HCMV early nuclear protein. J Virol Meth 1988; 22: 31.
33. Vogel JU, Cinatl J, Lux A, Weber B, Driesel AJ, Doerr HW. A new PCR assay for rapid and quantitative detection of human cytomegalovirus in cerebrospinal fluid. J Clin Microbiol, 1996; in press.
34. Blaheta RA, Scholz M, Hailer NP, Bereiter-Hahn J, Encke A, Markus BH. Adhesion and penetration properties of human lymphocytes acting on allogeneic vascular endothelial cells. Immunology 1994; 81: 538.
35. Kerr-Conte J, Boudjema K, Southard J, Cinqualbre J. Mechanism of hypothermic cell death: glutathione prevents injury in hepatocytes during hypothermie (4°C) preservation. Transplant Proc 1991; 23: 2405.
36. Kuntz-Simon G, Obert G. Sodium valproate, an anticonvulsant drug, stimulates human cytomegalovirus replication. J Gen Virol 1995; 76: 1409.
37. κB. Virology 1995; 206: 197.
38. Cinatl J, Cinatl J, Weber B, et al. In vitro inhibition of human cytomegalovirus replication in endothelial cells by ascorbic acid 2-phosphate. Antiviral Res 1995; 27: 405.
39. Murata A, Uike M. Mechanism of inactivation of bacteriophage HS2 containing single stranded RNA by ascorbic acid. J Nutr Sci Vitaminol 1976; 22: 347.
40. Ho WZ, Douglas SD. Glutathione and N-acetylcysteine suppression of human immunodeficiency virus replication in human monocyte/macrophages in vitro. AIDS Res Hum Retroviruses 1992; 8: 1249.
41. Palamara AT, Ciriolo MR, Bue C, et al. Antiviral action of glutathione: study on the mechanism [Abstract 164]. Antiviral Res Suppl 1994; 23: 123.
42. Cinatl J, Scholz M, Weber B, et al. Effects of Desferrioxamine on human cytomegalovirus replication and expression of HLA antigens and adhesion molecules in human vascular endothelial cells. Transplant Immunol 1995; 3: 295.